Sg Americas Securities, LLC Cassava Sciences Inc Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 17,475 shares of SAVA stock, worth $41,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,475
Holding current value
$41,066
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$9.57 - $35.08 $167,235 - $613,023
17,475 New
17,475 $514,000
Q4 2023

Jan 12, 2024
SELL
$12.64 - $30.11 $2.33 Million - $5.54 Million
-184,073 Reduced 66.59%
92,359 $2.08 Million
Q3 2023

Oct 13, 2023
BUY
$16.64 - $25.32 $2.14 Million - $3.26 Million
128,770 Added 87.21%
276,432 $4.6 Million
Q2 2023

Jul 10, 2023
SELL
$21.59 - $27.88 $680,667 - $878,972
-31,527 Reduced 17.59%
147,662 $3.62 Million
Q1 2023

Apr 28, 2023
BUY
$23.46 - $36.44 $3.37 Million - $5.24 Million
143,752 Added 405.66%
179,189 $4.32 Million
Q4 2022

Feb 02, 2023
BUY
$27.82 - $44.16 $842,862 - $1.34 Million
30,297 Added 589.44%
35,437 $1.05 Million
Q3 2022

Oct 31, 2022
SELL
$16.33 - $51.06 $757,009 - $2.37 Million
-46,357 Reduced 90.02%
5,140 $215,000
Q2 2022

Jul 29, 2022
BUY
$17.22 - $38.47 $776,346 - $1.73 Million
45,084 Added 703.01%
51,497 $1.45 Million
Q1 2022

Apr 29, 2022
BUY
$32.6 - $53.05 $25,558 - $41,591
784 Added 13.93%
6,413 $238,000
Q4 2021

Feb 07, 2022
SELL
$36.77 - $90.91 $5.05 Million - $12.5 Million
-137,259 Reduced 96.06%
5,629 $246,000
Q3 2021

Nov 01, 2021
BUY
$41.79 - $135.3 $5.9 Million - $19.1 Million
141,251 Added 8628.65%
142,888 $8.87 Million
Q2 2021

Aug 12, 2021
SELL
$32.15 - $89.72 $115,161 - $321,377
-3,582 Reduced 68.63%
1,637 $140,000
Q1 2021

May 13, 2021
BUY
$7.09 - $87.95 $37,002 - $459,011
5,219 New
5,219 $235,000
Q3 2020

Nov 09, 2020
SELL
$2.86 - $11.51 $35,967 - $144,749
-12,576 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$2.04 - $9.64 $25,655 - $121,232
12,576 New
12,576 $39,000

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $94.2M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email